Tag
A new narrative review synthesizing evidence from 1980 to 2025 argues that schizophrenia spectrum disorders cannot be explained solely by dopaminergic dysfunction. The authors propose a pluralistic model involving multiple neurochemical and cellular processes, with implications for treatment development and biomarker-based stratification.
This study evaluates the association of dopamine-enhancing drugs, especially levodopa, with lowered 3-year risk of progression from non-neovascular to neovascular AMD, offering promising insight into dopaminergic pathways in AMD management.
Discover how dopamine neurons in the brain’s reward center overpower satiety signals, driving hedonic eating even when we’re full, revealing new insights for obesity treatment.
Brief daily low-stakes exchanges—‘the clouds look like cotton candy’—build safety, activate reward circuits and sustain intimacy. Science explains why micro-connections matter and how clinicians and couples can use a 3‑minute practice to st
